FAQ & Research Knowledge Centre

BodyTech • Research education

Read the research behind the headline

Learn what a study can tell you, how clinical trials are designed, and why an early result is different from an approved treatment. These answers help you assess evidence in peptide and health research.

Updated 3 October 2026 · 10 questions with source links

Research foundations

What is preclinical research?

Preclinical research takes place before testing a potential treatment in people. It can include experiments in laboratory systems and animals to investigate biological activity and possible toxicity. These findings help researchers decide whether further study is justified; they do not establish clinical benefit in humans.

Source: FDA: Preclinical research

Do cell or animal studies prove that a treatment works in people?

No. Cell and animal studies can help researchers investigate mechanisms and potential risks, but they cannot replace human clinical research. A claim about a treatment’s effects in people needs relevant human evidence, including information about the study population and how outcomes were measured.

Source: FDA: Clinical research

What is the difference between an observational study and a clinical trial?

An observational study follows people without assigning the treatment or exposure being investigated. In an interventional clinical trial, researchers assign an intervention and evaluate its effects. The design matters because different kinds of studies answer different questions and have different limitations.

Source: NIH: Understanding clinical studies

Does an association mean that one thing caused another?

No. An association means two things occurred together in the data. Other factors may explain the relationship. Observational findings can raise useful questions, but a correlation alone does not establish that changing one factor will cause the other outcome.

Source: NIH: Understanding clinical studies

Trial design

What does randomized mean in a study?

Randomized means participants are assigned to study groups by chance. This helps reduce systematic differences between groups when comparing outcomes. It is a feature of study design, rather than a guarantee that the study is large enough or that its findings apply to everyone.

Source: NIH: Clinical research basics

What is a placebo-controlled trial?

A placebo-controlled trial compares an intervention with an inactive treatment designed to resemble it. The comparison helps researchers evaluate whether observed effects are attributable to the intervention. The exact comparison and other care provided should be checked in the study’s methods.

Source: NIH: Clinical research basics

What does blinded mean?

Blinding means keeping specified people unaware of which intervention a participant receives. Depending on the design, this may include participants, investigators or outcome assessors. It helps reduce expectations influencing behaviour or assessments; the study should explain who was blinded.

Source: NIH: Research glossary

What is a study endpoint?

An endpoint is an outcome a study uses to evaluate an intervention. Examples include a defined change in a measurement or the occurrence of a clinical event. Check the specified outcome and measurement period before deciding what a reported result actually demonstrates.

Source: NCI: Endpoint definition

Reading results

What do Phase 1, Phase 2 and Phase 3 mean?

Phase 1 usually focuses on initial safety and how a drug behaves in the body. Phase 2 explores effectiveness and safety in people with the condition. Phase 3 evaluates safety and effectiveness in larger groups. Progressing through these stages is separate from receiving market authorization.

Source: Health Canada: Clinical trials and authorization

Does authorization for a Canadian clinical trial mean a drug is approved for sale?

No. Authorization to study a drug in a clinical trial is different from market authorization. Health Canada describes investigational drugs as drugs being studied, and explains that sponsors can seek regulatory review after Phase 3. A trial announcement should not be read as an approval announcement.

Source: Health Canada: Clinical trials and authorization

Continue learning

New to the terminology? Read our peptide basics and terminology guide on BodyTechPharma.ca.